|4Feb 24, 8:42 PM ET

Cappel Markus J. 4

4 · ChemoCentryx, Inc. · Filed Feb 24, 2022

Insider Transaction Report

Form 4
Period: 2022-02-22
Cappel Markus J.
Chief Bus. Officer & Treasurer
Transactions
  • Award

    Stock Option (right to buy)

    2022-02-22+51,40051,400 total
    Exercise: $29.83Exp: 2032-02-22Common Stock (51,400 underlying)
  • Award

    Restricted Stock Units

    2022-02-22+40,70040,700 total
    Common Stock (40,700 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.
  • [F2]The restricted stock units awarded on February 22, 2022, vests in four equal installments on January 1, 2023, January 1, 2024, January 1, 2025, and January 1, 2026, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.
  • [F3]The option was granted on February 22, 2022, and 25% of the total number of shares of common stock subject to the option vests on January 1, 2023, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date.
  • [F4]Not applicable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION